Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Galantamine”

Showing 9 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT00226824
What this trial is testing

Safety Study of Galantamine in Tic Disorders

Who this might be right for
Tourette's SyndromeMotor Tic DisorderVocal Tic Disorder
Parkinson's Disease and Movement Disorders Center 1
Testing effectiveness (Phase 2)Study completedNCT00809835
What this trial is testing

Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse

Who this might be right for
Cocaine Dependence
Yale University 120
Large-scale testing (Phase 3)Study completedNCT00309725
What this trial is testing

A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.

Who this might be right for
Alzheimer's Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 139
Not applicableStudy completedNCT01194336
What this trial is testing

Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance

Who this might be right for
Biomarkers, Pharmacological
U.S. Army Medical Research and Development Command 84
Post-approval studies (Phase 4)Study completedNCT00176423
What this trial is testing

Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Maryland, Baltimore 117
Large-scale testing (Phase 3)Study completedNCT00253201
What this trial is testing

The Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 636
Large-scale testing (Phase 3)Study completedNCT00077727
What this trial is testing

The Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 107
Early research (Phase 1)Study completedNCT01417429
What this trial is testing

Galantamine Effects on Nicotine Responses in Smokers

Who this might be right for
SmokingTobacco Withdrawal
Yale University 12
Large-scale testing (Phase 3)Study completedNCT00236431
What this trial is testing

Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Who this might be right for
DementiaAlzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1,063

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation